WALTHAM, Mass.--(BUSINESS WIRE)--Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced a scientific poster presentation highlighting ATACs ...
Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced a moderated digital poster presentation at ...
ASC30 is an investigational GLP-1R biased small molecule agonist and has unique and differentiated properties that enable the same small molecule for both oral tablet and subcutaneous injection ...
STATEN ISLAND, N.Y., Sept. 27, 2021 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of ...
BETHESDA, Md.--(BUSINESS WIRE)--Precision Biologics, Inc. (“Precision”), a clinical-stage immunotherapy and targeted oncology company, will present at the SITC 37th Annual Meeting (2022) in Boston, MA ...
Presenting your poster at a Labroots Virtual Event can provide valuable research insights and feedback from peers in the comfort of your home or office. Every Labroots virtual event features a virtual ...
Every other year in February, the world of oceanography descends upon a conference center somewhere in the world to talk science, showcase innovations and network. It is a chance to see and be seen ...
GTx Announces Symposium and Presentation of Scientific Poster Presentations on Enobosarm at the 2013
GTx Announces Symposium and Presentation of Scientific Poster Presentations on Enobosarm at the 2013 MASCC/ISOO International Symposium on Supportive Care in Cancer Additionally, the Company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback